Saturday, October 31, 2026

Credit Acceptance Corporation Stock Rises By 31% In The Last 21 Sessions

ViaNews Editorial Team

February 3, 2023

Credit Acceptance Corporation Stock Rises By 31% In The Last 21 Sessions

(VIANEWS) - Shares of Credit Acceptance Corporation (NASDAQ: CACC) rose by a staggering 31.75% in 21 sessions from $403.49 at 2023-01-04, to $531.60 at 14:30 EST on Friday, after three successive sessions in a row of gains. NASDAQ is dropping 1.22% to $12,052.15, after three consecutive sessions in a row of gains.

Credit Acceptance Corporation's last close was $548.99, 15.4% below its 52-week high of $648.95.

About Credit Acceptance Corporation

Credit Acceptance Corporation provides financing programs, and related products and services to independent and franchised automobile dealers in the United States. The company advances money to dealers in exchange for the right to service the underlying consumer loans; and buys the consumer loans from the dealers and keeps various amounts collected from the consumers. It is also involved in the business of reinsuring coverage under vehicle service contracts sold to consumers by dealers on vehicles financed by the company. The company was founded in 1972 and is headquartered in Southfield, Michigan.

Earnings Per Share

As for profitability, Credit Acceptance Corporation has a trailing twelve months EPS of $40.02.

PE Ratio

Credit Acceptance Corporation has a trailing twelve months price to earnings ratio of 13.28. Meaning, the purchaser of the share is investing $13.28 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 40.34%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Credit Acceptance Corporation's stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

Credit Acceptance Corporation's stock is valued at $531.60 at 14:30 EST, way under its 52-week high of $648.95 and way higher than its 52-week low of $358.00.

Moving Average

Credit Acceptance Corporation's value is way above its 50-day moving average of $447.36 and above its 200-day moving average of $502.62.

Revenue Growth

Year-on-year quarterly revenue growth declined by 41.1%, now sitting on 1.5B for the twelve trailing months.

More news about Credit Acceptance Corporation (CACC).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com